STOCK TITAN

Willis Towers Watson (NASDAQ: WTW) president receives new RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Willis Towers Watson executive Julie Jarecke Gebauer reported new awards of restricted share units (RSUs) linked to the company’s ordinary shares. On January 12, 2026, she acquired 249.6278 RSUs and 12.0242 RSUs, each priced at $329.45 per unit. Each RSU represents the right to receive one ordinary share with a nominal value of $0.000304635 per share.

Some RSUs were credited under the Willis Towers Watson Non-Qualified Deferred Savings Plan and the Non-Qualified Stable Value Excess Plan for U.S. Employees, reflecting both the participant’s deferral elections and company matching contributions. The RSUs generally settle into ordinary shares on a 1:1 basis following the reporting person’s termination or separation from service, or earlier upon death, based on the specific plan terms.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gebauer Julie Jarecke

(Last) (First) (Middle)
C/O WILLIS GROUP LIMITED
51 LIME STREET

(Street)
LONDON X0 EC3M 7DQ

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
WILLIS TOWERS WATSON PLC [ WTW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Pres.-Health, Wealth & Career
3. Date of Earliest Transaction (Month/Day/Year)
01/12/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Share Unit (1) 01/12/2026 A 249.6278(2) (1) (1) Ordinary Shares, nominal value $0.000304635 per share 249.6278 $329.45 23,902.3092 D
Restricted Share Unit (3) 01/12/2026 A 12.0242(4) (3) (3) Ordinary Shares, nominal value $0.000304635 per share 12.0242 $329.45 5,477.3278 D
Explanation of Responses:
1. Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.
2. Includes restricted share units acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.
3. Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.
4. Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.
/s/ Julie J. Gebauer by Lina Vanessa Jaramillo, Attorney-in-Fact (power of attorney previously filed) 01/14/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Willis Towers Watson (WTW) report in this Form 4?

The filing reports that Julie Jarecke Gebauer, President of Health, Wealth & Career at Willis Towers Watson, acquired new restricted share units (RSUs) tied to the company’s ordinary shares on January 12, 2026.

How many restricted share units did Julie Gebauer acquire in the latest WTW Form 4?

Julie Gebauer acquired 249.6278 restricted share units in one transaction and 12.0242 restricted share units in a second transaction, each at a reference price of $329.45 per unit.

What do the WTW restricted share units reported in this filing convert into?

The restricted share units settle into Willis Towers Watson ordinary shares on a 1:1 basis, each with a nominal value of $0.000304635 per share, according to the plan terms described.

Which Willis Towers Watson compensation plans are involved in these RSU awards?

The RSUs include units acquired under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees and the Non-Qualified Stable Value Excess Plan for U.S. Employees, reflecting deferral elections and related company matching contributions.

When do the reported Willis Towers Watson RSUs settle into ordinary shares?

Under the described plan terms, certain RSUs settle into ordinary shares six months after the reporting person’s termination or separation from service, or on the first eligible business day following that date, and may settle earlier upon death, depending on the specific plan.

Does this WTW Form 4 indicate direct or indirect ownership of the RSUs?

The Form 4 shows that the RSUs are held with direct (D) ownership by the reporting person, as indicated in the ownership column of the derivative securities table.

Willis Towers

NASDAQ:WTW

WTW Rankings

WTW Latest News

WTW Latest SEC Filings

WTW Stock Data

31.45B
95.46M
0.25%
97.48%
2.82%
Insurance Brokers
Insurance Agents, Brokers & Service
Link
United Kingdom
LONDON ENGLAND